Measurement of the internal dose to families of outpatients treated with 131I for hyperthyroidism

被引:19
作者
Barrington, S. F. [1 ]
Anderson, P. [2 ]
Kettle, A. G. [3 ]
Gadd, R. [4 ]
Thomson, W. H. [5 ]
Batchelor, S. [6 ]
Mountford, P. J. [4 ]
Harding, L. K. [5 ]
O'Doherty, M. J. [1 ]
机构
[1] St Thomas Hosp, PET Imaging Ctr, London SE1 7EH, England
[2] Queen Elizabeth Hosp, Dept Nucl Med, Birmingham B15 2TH, W Midlands, England
[3] E Kent Hosp NHS Trust, Kent & Canterbury Hosp, Dept Nucl Med, Canterbury, Kent, England
[4] Univ Hosp N Staffordshire, Directorate Med Phys & Clin Technol, Stoke On Trent, Staffs, England
[5] City Hosp, Dept Phys & Nucl Med, Birmingham, W Midlands, England
[6] Guys & St Thomas Hosp, Dept Med Phys, London SE1 9RT, England
关键词
Radiation dose; Radiation protection; Iodine radioisotopes; Thyroid gland; Hyperthyroidism therapy;
D O I
10.1007/s00259-008-0892-0
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective The aim of this study was to measure the internal dose received by family members from ingestion of radioactive contamination after outpatient therapy. Materials and methods Advice was given to minimise transfer of radioiodine. Home visits were made approximately 2, 7 and 21 days after treatment to measure radioactivity in the thyroids of family members. A decay correction was applied to radioactivity detected assuming ingestion had occurred at the earlier contact time, either the day of treatment or the previous home visit. An effective half-life of 6 or 7 days was used depending on age. Thyroid activity was summed if activity was found at more than one visit in excess of the amount attributable to radioactive decay. Effective dose (ED) was calculated using ICRP72. Results and discussion Fifty-three adults and 92 children, median age 12 (range 4-17) years participated. Median administered activity was 576 (range 329-690) MBq I-131. Thyroid activity ranged from 0 to 5.4 kBq in the adults with activity detected in 17. Maximum adult ED was 0.4 mSv. Thyroid activity ranged from 0 to 11.8 kBq in the children with activity detected in 26. The two highest values of 5.0 and 11.8 kBq occurred in children aged 5 and 14 years from different families. Eighty-five children had no activity or < 1 kBq detected. ED was < 0.2 mSv in 86 out of 92 children (93%). Previous published data showed 93% of children received an ED <= 0.8 mSv from external irradiation. Conclusion With advice, families of outpatients receiving radioiodine should be able to comply with statutory dose limits and constraints.
引用
收藏
页码:2097 / 2104
页数:8
相关论文
共 27 条
  • [1] Radiation exposure of the families of outpatients treated with radioiodine (iodine-131) for hyperthyroidism
    Barrington, SF
    O'Doherty, MJ
    Kettle, AG
    Thomson, WH
    Mountford, PJ
    Burrell, DN
    Farrell, RJ
    Batchelor, S
    Seed, P
    Harding, LK
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (07) : 686 - 692
  • [2] RADIOIODINE THERAPY TO OUT-PATIENTS - RADIATION HAZARD
    BUCHAN, RCT
    BRINDLE, JM
    [J]. BRITISH JOURNAL OF RADIOLOGY, 1971, 44 (528) : 973 - &
  • [3] RADIOIODINE THERAPY TO OUT-PATIENTS - CONTAMINATION HAZARD
    BUCHAN, RCT
    BRINDLE, JM
    [J]. BRITISH JOURNAL OF RADIOLOGY, 1970, 43 (511) : 479 - &
  • [4] Risk of thyroid cancer after exposure to 131I in childhood
    Cardis, E
    Kesminiene, A
    Ivanov, V
    Malakhova, I
    Shibata, Y
    Khrouch, V
    Drozdovitch, V
    Maceika, E
    Zvonova, I
    Vlassov, O
    Bouville, A
    Goulko, G
    Hoshi, M
    Abrosimov, A
    Anoshko, J
    Astakhova, L
    Chekin, S
    Demidchik, E
    Galanti, R
    Ito, M
    Korobova, E
    Lushnikov, E
    Maksioutov, MA
    Masyakin, V
    Nerovnia, A
    Parshin, V
    Parshkov, E
    Piliptsevich, N
    Pinchera, A
    Polyakov, S
    Shabeka, N
    Suonio, E
    Tenet, V
    Tsyb, A
    Yamashita, S
    Williams, D
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (10): : 724 - 732
  • [5] Thyroid neoplasia, autoimmune thyroiditis, and hypothyroidism in persons exposed to iodine 131 from the Hanford Nuclear Site
    Davis, S
    Kopecky, KJ
    Hamilton, TE
    Onstad, L
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (21): : 2600 - 2613
  • [6] *EUR COMM, 1997, RAD PROT 97 RAD PROT
  • [7] Individual thyroid dose estimation for a case-control study of Chernobyl-related thyroid cancer among children of Belarus -: Part I:: 131I, short-lived radioiodines (132I, 133I, 135I), and short-lived radiotelluriums (131MTe and 132Te)
    Gavrilin, Y
    Khrouch, V
    Shinkarev, S
    Drozdovitch, V
    Minenko, V
    Shemiakina, E
    Ulanovsky, A
    Bouville, A
    Anspaugh, L
    Voillequé, P
    Luckyanov, N
    [J]. HEALTH PHYSICS, 2004, 86 (06): : 565 - 585
  • [8] Radiation exposure from outpatient radioactive iodine (131I) therapy for thyroid carcinoma
    Grigsby, PW
    Siegel, BA
    Baker, S
    Eichling, JO
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (17): : 2272 - 2274
  • [9] IBIS E, 1992, J NUCL MED, V33, P2110
  • [10] Institute of Physics and Engineering in Medicine, 2002, MED DENT GUID NOT GO